Efficacy and Safety of the All-Oral Schedule of Metronomic Vinorelbine and Capecitabine in Locally Advanced or Metastatic Breast Cancer Patients: The Phase I-II VICTOR-1 Study

Background. Vinorelbine (VRB) and capecitabine (CAPE) are demonstrated to be active in pretreated metastatic breast cancer patients. Different studies have demonstrated that the metronomic treatment is active with an acceptable toxicity profile. We designed a Phases I-II study to define the MTD of o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cazzaniga, M. E., Torri, V., Villa, F., Giuntini, N., Riva, F., Zeppellini, A., Cortinovis, D., Bidoli, P.
Formato: Artigo
Lenguaje:Inglês
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3914392/
https://ncbi.nlm.nih.gov/pubmed/24551455
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/769790
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares